NIH-funded research U01 cooperative agreement

Diabetic Foot Ulcer Clinical Unit

Official title: NIDDK Diabetic Foot Consortium Clinical Research Unit

Funded at University of Michigan at Ann Arbor · NIH-11257687 · Data updated 2026-11-12

This program aims to bring quick bedside tests (biomarkers) into clinics to help people with diabetes and foot ulcers get faster, clearer care.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 15, 2018
Project endDecember 31, 2027
Funding year2026
Award (this year)$727,080
NIH project number5U01DK119083-09
Project IDNIH-11257687 on NIH RePORTER

Who could benefit from this research

Could help

Adults with diabetes who currently have or recently healed diabetic foot ulcers, or who are receiving care at participating wound clinics, are the most likely candidates to join.

Less likely to help

People without diabetes, without foot wounds, or those unable to attend participating clinical sites are unlikely to benefit directly from this program.

What this research studies

If you have diabetes and a foot ulcer, this clinical unit works to collect samples and test simple markers that might show if a wound is infected or not healing. The team runs a master protocol with smaller substudies to finalize and standardize these biomarker tests and how they would be used in clinic visits. The project links clinics, lab testing, and data analysis so results can be used at the point of care rather than waiting for long lab turnaround. The goal is to move promising tests from early work into real-world use across participating sites.

Why it matters

Potential benefit: Successful point-of-care biomarkers could lead to earlier problem detection, more targeted treatments, and fewer amputations for people with diabetic foot ulcers.

How similar studies have gone: Earlier pilot work and the first cycle of the Diabetic Foot Consortium showed promising biomarker leads, but larger validation and implementation are still needed.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Holmes, Crystal Murray — University of Michigan at Ann Arbor
  • Study coordinator: Holmes, Crystal Murray

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.